# Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD (BS8X) **Source:** https://fundology.uk/fund/bs8x · ISIN IE000GMRDSZ7 · Data: TradingView (LSE closes and returns, delayed), issuer documents and holdings (Invesco), ONS CPIH, FCA FIRDS ## At a glance > Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise. As of 01/10/2026, BS8X (Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD, ISIN IE000GMRDSZ7) closed at £4.40 on the London Stock Exchange. Its ongoing charge is 0.10% a year (about £10 on £10,000). Over the year to 01/10/2026 its total return was +3.7%, or +0.4% after UK CPIH inflation. ## Summary Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD is an exchange-traded fund (ETF) from Invesco, launched in 2024. It tracks the Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net. You buy and sell it through a share-dealing account or platform during stock-market hours, like a share. Its ongoing charge is 0.1% a year — about £10 a year on every £10,000 invested, taken from the fund's value rather than billed to you. Income from its investments is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. Latest close: **£4.40** (01/10/2026). ## Key facts | Fact | Value | |---|---| | Ticker (LSE) | BS8X | | ISIN | IE000GMRDSZ7 | | Category | Corporate & other bonds | | Type | ETF | | Provider | Invesco | | Tracks | Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net | | Income | Accumulating | | Ongoing charge | 0.10% a year (£10 per £10,000) | | Fund size | £11.4m | | Launched | 2024 | | Domicile | Ireland | ## Past returns (periods to 01/10/2026) After the fund's ongoing charges. "Income reinvested" is total return; "price only" leaves out income paid out. Real returns are after ONS CPIH inflation. | Window | Return | After CPIH inflation | Measured as | |---|---|---|---| | 1 year | +3.67% | +0.42% | income reinvested | Returns: TradingView (delayed data). Inflation: ONS CPIH, latest month published. ## Charges compared with similar funds Ongoing charge of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD 0.10% a year, as of 02/10/2026: 356 of the 392 other corporate and other bond funds charge more, 24 the same and 12 less (share classes counted once). ## Funds tracking the same index 4 funds track Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net, this one included and share classes counted once; their ongoing charges range from 0.10% to 0.12% a year (01/10/2026). | Fund | Ongoing charge | 1 year | 3 years | 5 years | |---|---|---|---|---| | Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- Hedged GBP | 0.12% | +1.0% | — | — | | Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD (this fund) | 0.10% | +3.7% | — | — | | Invesco Markets II plc - Invesco BulletShares 2028 USD Corporate Bond UCITS ETF - USD | — | +3.7% | — | — | | Invesco Markets II plc - Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Hedged GBP | — | +2.2% | — | — | Returns are the data vendor’s, in pounds, income reinvested unless marked "(price)". ## Charges & eligibility - Ongoing charges figure (OCF): **0.10%** per year - ISA eligible: yes - SIPP eligible: yes ## What it holds As of 30/09/2026, BS8X holds 592 positions, according to the holdings Invesco publishes. The largest is CVS Health Corp 4.3% 25/03/28 at 1.02% of the fund; the ten largest make up 7.5%. ### Top holdings Largest positions (as of 30/09/2026), as a percentage of the whole fund: | # | Holding | Ticker | Weight | |---|---|---|---| | 1 | CVS Health Corp 4.3% 25/03/28 | — | 1.02% | | 2 | Cigna Group/The 4.375% 15/10/28 | — | 0.79% | | 3 | Salesforce Inc 4.5% 15/03/28 | — | 0.79% | | 4 | Pfizer Investment Enterprises Pte 4.45% 19/05/28 | — | 0.78% | | 5 | Comcast Corp 4.15% 15/10/28 | — | 0.76% | | 6 | AerCap Ireland Capital DAC / AerCa 3% 29/10/28 | — | 0.73% | | 7 | Amgen Inc 5.15% 02/03/28 | — | 0.73% | | 8 | NVIDIA Corp 4.25% 15/06/28 | — | 0.73% | | 9 | Morgan Stanley VAR 22/07/28 | — | 0.64% | | 10 | Citibank Na 5.803% 29/09/28 | — | 0.54% | Source: Invesco, holdings as published, as of 30/09/2026. ## Where it invests Shares of the whole fund. Bonds, cash and positions the source does not classify are shown as they come, not guessed. ### By type of asset Added up from the holdings Invesco publishes, as of 30/09/2026. | Type of asset | Weight | |---|---| | Bonds | 99.8% | | Cash and money market | 0.2% | All 592 holdings: https://fundology.uk/fund/bs8x/holdings ## Questions people ask **What is the ongoing charge of BS8X?** The ongoing charge of BS8X is 0.10% a year — about £10 a year on every £10,000 invested, taken from the fund’s value rather than billed to you. Platform and dealing fees are charged separately. Ongoing charge of Invesco BulletShares 2028 USD Corporate Bond UCITS ETF Accum- USD 0.10% a year, as of 02/10/2026: 356 of the 392 other corporate and other bond funds charge more, 24 the same and 12 less (share classes counted once). **What does BS8X track?** BS8X tracks the Bloomberg 2028 Maturity USD Corporate Bond Screened Index - Benchmark TR Net. **Is BS8X accumulating or distributing?** BS8X is accumulating: income is reinvested inside the fund, so it shows up as a rising price rather than cash paid to you. **What is the ISIN of BS8X?** The ISIN of BS8X is IE000GMRDSZ7. An ISIN identifies one exact share class of a fund; BS8X is its ticker on the London Stock Exchange. **What does BS8X hold?** As of 30/09/2026, BS8X holds 592 positions, according to the holdings Invesco publishes. The largest is CVS Health Corp 4.3% 25/03/28 at 1.02% of the fund; the ten largest make up 7.5%. Its ten largest holdings are CVS Health Corp 4.3% 25/03/28 (1.02%), Cigna Group/The 4.375% 15/10/28 (0.79%), Salesforce Inc 4.5% 15/03/28 (0.79%), Pfizer Investment Enterprises Pte 4.45% 19/05/28 (0.78%), Comcast Corp 4.15% 15/10/28 (0.76%), AerCap Ireland Capital DAC / AerCa 3% 29/10/28 (0.73%), Amgen Inc 5.15% 02/03/28 (0.73%), NVIDIA Corp 4.25% 15/06/28 (0.73%), Morgan Stanley VAR 22/07/28 (0.64%) and Citibank Na 5.803% 29/09/28 (0.54%). **How has BS8X done after inflation?** Over the year to 01/10/2026 BS8X’s total return was +3.7%, or +0.4% after UK CPIH inflation. Past performance is not a guide to future returns. --- We show information. We are not financial advisers, not authorised by the FCA, and never recommend specific investments. Capital at risk. Past performance is not a guide to future returns. The value of investments can fall as well as rise.